Tag : COGNITIVE DECLINE
Dementia affects over 57 million people globally, with numbers projected to triple by 2050 due to population aging. While Alzheimer’s disease (AD) dominates clinical focus and public attention, vascular dementia (VaD), the second most common subtype, poses its own set of diagnostic challenges, and a compelling opportunity for prevention through effective vascular risk management and multidisciplinary care.
Patients presenting with faster-than-expected cognitive decline may have rapidly progressive dementia (RPD) or a condition that stabilizes or reverts to a more typical progression. Early distinction between “true” RPD and non-RPD cases is critical, as true RPDs rapidly impair cognition and function